IL10 and Stroke: This is the case for the anti‐inflammatory cytokine IL‐10, which has been found to be substantially increased at the onset of stroke in those patients who will develop poststroke infections within the first week after stroke and has even been proposed as a robust independent prognostic biomarker for these infectious complications (Chamorro et al, 2006; Ashour et al, 2016).